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Barcelona, SpainAbstractIn order to describe the molecular epidemiology of human
rhinovirus (HRV) and enterovirus (EV) infection in severely ill
children, we studied all episodes of bronchospasm/
bronchopneumonia in 6-month-old to 18-year-old patients from
January 2010 to May 2012 who required mechanical ventilation.
HRV/EVs were detected in 55 (57.3%) of 96 patients, of which
50 (91%) were HRV (HRV-A, 16; HRV-B, 1; HRV-C, 18) and 5
(9%) were EVs (EV-D68, 3). No signiﬁcant differences in
epidemiologic and clinical characteristics were found between
different types. In six of the 13 patients who required invasive
mechanical ventilation, HRV was the only pathogen detected.
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Passeig Sant Joan de Déu, n° 2, 08950 Esplugues, Barcelona, SpainClinical Microbiology and Infection © 2015 European Society of ClinicE-mail: claunes@hsjdbcn.orgHuman rhinoviruses (HRVs) and enteroviruses (EVs) are RNA
viruses belonging to the genus Enterovirus of the family
Picornaviridae. Genome sequencing revealed three species (A,
B and C) of HRV and 10 (A to J) of EV, with more than 100
types of each one. Because of the high genetic similarity be-
tween EVs and HRVs, some commercial multiplex RT-PCR
assays are not able to distinguish between EVs and HRVs. Pi-
cornaviruses are the most frequently detected respiratory vi-
ruses among paediatric and adult populations [1,2]. They are a
common cause of mild respiratory infections, but severe
manifestations can also be observed in children, in particular
immunosuppressed patients [2,3]. Of note, outbreaks of critical
respiratory illness caused by a speciﬁc type of EV (EV-D68)
were reported in the past in Europe and more recently in the
United States [4,5].
There are few data describing the molecular epidemiology of
HRVs and EVs in severely ill children. In the present study, all
patients aged 6months to 18 yearswith acute respiratory failure
due to bronchospasm/bronchopneumonia who were attended
in a paediatric intensive care unit (PICU) of a tertiary care
hospital (Hospital Sant Joan de Déu, Barcelona, Spain) from
January 2010 to May 2012 with laboratory conﬁrmation for
HRV/EV were included. Throughout the study period,
two different RT-PCR assays were used to detect HRV/EV in-
fections: RealAccurate Respiratory RT-PCR (Pathoﬁnder, The
Netherlands) during 2010, and xTAG Respiratory Viral Panel
(Abbott, USA) during 2011 and 2012. Phylogenetic analysis of
VP4/2 sequences (PMID 11807226) from all positive HRV/EV
samples was retrospectively performed in MEGA v5.2 (PMID
21546353), together with other sequences as references for
each HRV/EV type. Demographic and clinical variables of HRV/
EV-positive patients were prospectively collected.
SPSS software version 22.0 for Windows was used to
perform the statistical tests. This study was approved by Sant
Joan de Déu Ethical Assistant Committee.
During the period of study, 96 episodes of bronchospasm/
bronchopneumonia were treated in the PICU. HRV/EVs were
detected in respiratory samples from 55 (57.3%) patients, of
which 50 (91%) were HRV (HRV-A, 16; HRV-B, 1; HRV-C,
18; 15 could not be typed) and 5 (9%) were EVs (EV-D68,
3; 2 could not be typed).
Epidemiologic and clinical characteristics of patients with
typed HRV and EV infections (n = 38) are summarized in
Table 1. There was not enough sample to type the remaining 17
HRV/EV detections.Clin Microbiol Infect 2015; 21: 799.e5–799.e7
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TABLE 1. Characteristics of children with respiratory failure admitted to the PICU and rhinovirus and enterovirus detection
Characteristic Total Rhinovirus A Rhinovirus C Rhinovirus B Enterovirus D68 pa
No. of patients 38 16 18 1 3
Patient variables
Age group
6 months to 2 years 20 (53%) 8 (50%) 10 (56%) 1 1 (33%) 0.27
2–5 years 12 (32%) 6 (37%) 6 (33%) 0 0 (20%)
>5 years 6 (15%) 2 (12%) 2 (11%) 0 2 (67%)
Age (months)b 20.0 (12.2–40.7) 21.5 (10.5–34.7) 20.0 (13.0–40.7) 70.0 (41.5–71.0) 0.45
Sex (male) 24 (63%) 8 (50%) 12 (67%) 1 3 (100%) 0.31
Comorbidity 0.40
Respiratory disease 20 (53%) 8 (50%) 10 (56%) 0 2 (67%)
Other 7 (18%) 3 (19%) 4 (22%) 0 0 (0%)
No comorbidities 11 (29%) 5 (31%) 4 (22%) 1 1 (33%)
Clinical variables
Fever 19 (50%) 8 (50%) 9 (50%) 1 1 (33%) 0.72
Noninvasive MV
Conventional 24 (63%) 8 (50%) 13 (72%) 1 2 (67%) 0.48
IMV (n) 9 (24%) 5 (31%) 4 (22%) 0 0 (0%) 0.34
HFOV (n) 5 (13%) 3 (19%) 1 (6%) 0 1 (33%) 0.46
Days of IMVb 7.1 (3.6–9.8) 7.7 (3.2–9.3) 6.2 (4.2–15.7) 0.97
PICU stay (days)b 4.0 (3.0–11.2) 4.0 (2.2–12.0) 4.5 (3.0–10.0) 4.5 (5.0–8.0) 0.95
Hospital stay (days)b 7.0 (5.0–15.0) 8.0 (4.5–15.0) 7.5 (5.0–12.7) 7 (6.0–12.0) 0.96
Other viral codetections 5 (13%) 2 (12%) 2 (11%) 0 1 (33%) 0.73
Bacterial coinfectionc 5/12 (42%) 1/6 (17%) 3/5 (60%) 0/0 0/1 (0%) 0.24
Types (n) A49 (4), A101 (3), A1 (1), A11 (1),
A19 (1), A23 (1), A33 (1), A71 (1),
A78 (1), A82 (1)
C17 (6), C15 (4), C21 (2),
C1 (1), C10 (1), C12 (1),
C14 (1), C28 (1), C3 (1)
B52 (1)
MV, mechanical ventilation; IMV, invasive mechanical ventilation; HFOV, high-frequency oscillatory ventilation; PICU: pediatric intensive care unit.
aProportions between the four groups were compared by the Pearson chi-square test. For continuous variables, Kruskal-Wallis analysis was performed.
bMedian (interquartile range).
cPatients with cultures of bronchoalveolar lavage.
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35) were 6 months to 2 years old. Eighteen of 35 had a res-
piratory chronic condition (asthma or recurrent wheezing ep-
isodes with either chronic treatment or previous
hospitalizations). Nine patients underwent invasive conven-
tional ventilation, and four required high-frequency oscillation
ventilation (HFOV). Median PICU admission was 4 days
(interquartile range 3.0–12.0 days). The most common HRV
specie was HRV-C (18/35), followed by HRV-A (16/35), as
reported by others [6]. Signiﬁcant differences between HRV-A
and HRV-C were not found to be related to any of the patients’
epidemiologic and clinical characteristics (Table 1). However,
some series have shown that HRV-C could cause more severe
disease in children younger than 3 years [6]. Respiratory viral
codetections were found in four patients (two respiratory
syncytial virus, one adenovirus, one human parainﬂuenza 3),
which were not associated with either HRV species or severity,
as reported previously [6]. Cultures of bronchoalveolar lavage
were performed within the ﬁrst 72 hours of admission in 11
patients who underwent invasive mechanical ventilation. Bac-
terial coinfection was found in four of 11 (two Escherichia coli,
one Haemophilus inﬂuenzae, one Pseudomonas aeruginosa), a rate
similar to that reported by others [7]. Bacterial coinfected
patients had a median PICU stay of 17.5 days (interquartile
range 10.0–29.5 days). The role of HRV when it is detected in
acutely ill children is still being discussed because it shows long
viral persistence in respiratory tract in many cases [8], and in
addition, it is also detected in asymptomatic children [9,10].Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectHowever, although bacterial coinfections [11] play an important
role in the severity of HRV disease, a high rate of infection (6/
13, 46%) among patients requiring invasive mechanical ventila-
tion was conﬁrmed for single HRV detection in respiratory
specimens.
We found the number of patients who had asthma to be
remarkable. The rhinovirus-induced wheezing episodes in all
age ranges have been widely discussed, and the role of rhino-
viruses seems to be proven in wheezing children who are more
than 12 months old [12]. If we understand the relationship
between virus load and host immunoresponse, we could
perhaps identify the real role of rhinovirus detection in all
children [13–15].
On the other hand, all three EV-D68 patients required PICU
admission within the ﬁrst 48 hours of symptoms. Two of them
required noninvasive bilevel airway pressure support for 3 and
4 days, respectively. One was a previously healthy 14-month-
old patient and the other a 6-year-old boy with asthma. The
third patient was a 5-year-old boy with asthma who developed
severe respiratory failure requiring invasive mechanical venti-
lation (including HFOV) for 9 days. Despite the strong similarity
between EV-D68 and HRV, EV-D68 infection is more related to
severity than most of the HRV infections [4,5]. All the EV cases
were diagnosed in 2010 (from February to December) and
were likely related to an outbreak that occurred worldwide,
including Europe [4,16], while no additional cases were detec-
ted during 2011–2012. The two patients with EV infections that
could not be typed required HFOV. Despite this, it is difﬁcult toious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 799.e5–799.e7
CMI Launes et al. Molecular epidemiology of severe respiratory disease 799.e7draw conclusions regarding the clinical differences between
HRV and EV infections due to the small number of patients with
typed EV infection.
In conclusion, HRV was the only agent detected in a large
number of severely ill children. No differences in clinical or
epidemiologic variables were found between HRV-A and HRV-
C infections. Five patients with EV infection were identiﬁed
after typing the HRV/EV-positive results, and three of ﬁve were
severely ill children who required HFOV. This fact emphasizes
the need to improve the diagnostic tools available for respira-
tory virus screening in order to successfully distinguish between
HRV and EV. Genotyping should be performed to acquire more
knowledge about the circulation and clinical impact of each
type.Transparency declarationThis study was partially supported by “Fundación Godia.” All
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